Initiator Pharma A/S calls for the Annual General Meeting

About this update from Initiator Pharma A/s

Company reg. (CVR) no. 37663808Notice to convene the annual general meeting 2026The board of directors hereby convene the annual general meeting of Initiator Pharma A/S (the "Company") for 29 May 2026, at 10:00 AM CEST at the office of DLA Piper Denmark, Oslo Plads 2, 2100 Copenhagen OE, Denmark.AgendaThe agenda of the annual general meeting is the following:Appointment of chairman of the meetingThe board of directors’ reportAdoption of the annual reportA resolution to distribute the profit or cover the loss according to the adopted annual reportApproval of the remuneration of the board of directorsElection of members to the board of directorsAppointment of auditorAny proposals receivedPresentation and advisory vote on the Remuneration Report 2025Proposal from the board of directors to amend the authorisation to conduct capital increase with pre-emption rights in article 4a of the Company’s articles of associationProposal from the board of directors to amend the authorisation to conduct capital increase without pre-emption rights in article 4b of the Company’s articles of associationProposal from the board of directors to approve an authorisation for the board of directors to issue warrants with or without pre-emption rights for existing shareholders by inserting a new article 4h in the Company’s articles of associationAuthorisation to the chairman of the meetingAny other businessComplete proposalsRe item 1 Appointment of chairman of the general meetingThe board of directors proposes Ulrik Bangsbo Hansen as chairman of the general meeting.Re item 2 The board of directors’ reportThe board of directors proposes that the general meeting takes note of the board of directors’ report on the Company’s activities in the past financial year.Re item 3 Adoption of the annual reportThe board of directors proposes that the general meeting adopts the annual report.Re item 4 A resolution to distribute the profit or cover the loss according to the adopted annual reportThe board of directors proposes that the loss for the year as recorded in the annual report for 2025 as adopted by the general meeting be carried forward to next year.Re item 5 Approval of the remuneration of the board of directors.The board of directors proposes that chairman of the board of directors should receive 240,000 DKK and that ordinary board members should receive 120,000 DKK.CEO Claus Olesen has...

View stock analysis, news, and events for Initiator Pharma A/s